About 300 reports

In 2015, Sandoz received FDA approval for Zarxio, a biosimilar version of filgrastim for all the same indications as branded filgrastim.

  • Drug Discovery And Development
  • World
  • Amgen Inc.
  • Daiichi Sankyo Company
  • Eli Lilly & Co.
  • Clinical Trial profile. 278 Trial Title
  • Clinical Trial profile. 236 Trial Title
  • Blood Disease
  • Blood Supply
  • Clinical Trial
  • Drug Discovery And Development
  • World

Filgrastim or Lenograstim or CSF##), Interleukin ## (Cytokine Synthesis Inhibitory Factor or CISF or IL##), Interleukin ## (IL##), Interleukin ## (IL##), Interleukin ## (IL##), Interleukin ## (B Cell Stimulatory Factor ## or Binetrakin or Lymphocyte Stimulatory Factor ## or Pitrakinra or IL##),

  • Clinical Trial
  • Drug Discovery And Development
  • World
  • Product Initiative
  • Pfizer Inc.
  • Clinical Trial profile. 7 Trial Title
  • Clinical Trial profile. 140 Trial Title
  • Clinical Trial
  • Drug Discovery And Development
  • Leukemia
  • World
  • Product Initiative
  • Blood Supply
  • Drug Discovery And Development
  • Prostate Cancer
  • Therapy
  • OncBioMune Pharmaceuticals, Inc.
  • Clinical Trial profile. 33 Trial Title
  • Clinical Trial profile. 118 Trial Title
  • Cancer
  • Drug Discovery And Development
  • United States
  • World
  • Product Initiative
  • Clinical Trial profile. 153 Trial Title
  • PROMINENT DRUGS

filgrastim ## cyclophosphamide ## docetaxel (piperacillin sodium + tazobactam sodium) (piperacillin + tazobactam) Total Source: GlobalData' s Pharma Intelligence Center Clinical Trials Database (*)Trials are taken for a time period of 1995 - 2017 2017 trials are taken as of August 2017 ##

  • Clinical Trial
  • Drug Discovery And Development
  • Filgrastim
  • World
  • Amgen Inc.
  • Clinical Trial profile. 49 Trial Title
  • CLINICAL TRIAL PROFILE SNAPSHOTS
  • Clinical Trial
  • Drug Discovery And Development
  • Targeted Therapy
  • World
  • Product Initiative
  • Clinical Trial profile. 140 Trial Title
  • Clinical Trial profile. 422 Trial Title
  • Cancer
  • Drug Discovery And Development
  • United States
  • World
  • Product Initiative
  • Name

s Zarxio (filgrastim-sndz), in the U. S.

  • Clinical Trial
  • Drug Discovery And Development
  • World
  • Market Size
  • Medidata
  • Clinical Trial profile. 161 Trial Title

filgrastim; sargramostim Fred Hutchinson Cancer Research Center ## Mar 1995 ## Oct 1997 ## ## Clinical Trial profile. ## Trial Title Official Title Trial Identifier Secondary ID(s) Therapy Area Indication(s) Trial Status Trial Phase Study Type Drug(s)/ Molecule(s) Sponsor(s) Collaborato

  • Biological Therapy
  • Blood Disease
  • Drug Discovery And Development
  • World
  • Product Initiative

The FDA requires that the biosimilar INN is followed by a four letter suffix, denoting the product manufacturer name, such as filgrastim-sndz in the case of the filgrastim TABLE ##: TRASTUZUMAB BIOSIMILARS, 2017 ##. ##. ## NOMENCLATURE biosimilar by Sandoz.

  • Drug Discovery And Development
  • Forecast
  • Novartis AG
  • Pfizer Inc.
  • Roche Group
  • Clinical Trial profile. 153 Trial Title
  • Clinical Trial profile. 297 Trial Title

Flexible Filgrastim to Accelerate Bone Marrow Recovery after Chemotherapy in Children with Cancer GDCT## NCT##, 2013-##; NCI-2013-02001; 2013-##; P##CA##; CDR## Oncology Brain Tumor, Germ Cell Tumors, Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma), Medulloblastoma, Neuroblastom

  • Chemotherapy
  • Clinical Trial
  • Drug Discovery And Development
  • United States
  • World
  • Clinical Trial profile. 11 Trial Title
  • Clinical Trial profile. 16 Trial Title

Mast Cell Leukemia Global Clinical Trials Review, H##, 2017 HEA LTH CA REHEA LTH CA RE REFERENCE CODE: GDHC##CTIDB PUBLICATION DATE: DEC 2017 LIST OF TABLES Mast Cell Leukemia Global Clinical Trials Review, H##, 2017 outlines clinical trials in Mast Cell Leukemia.

  • Drug Discovery And Development
  • Leukemia
  • World
  • Product Initiative
  • Novartis AG

Gallbladder Cancer Global Clinical Trials Review, H##, 2017 HEA LTH CA REHEA LTH CA RE REFERENCE CODE: GDHC##CTIDB PUBLICATION DATE: AUG 2017 LIST OF TABLES Gallbladder Cancer Global Clinical Trials Review, H##, 2017 outlines clinical trials in Gallbladder Cancer.

  • Chemotherapy
  • Clinic
  • Clinical Trial
  • Drug Discovery And Development
  • Eli Lilly & Co.

Menstrual Disorders Global Clinical Trials Review, H##, 2017 HEA LTH CA REHEA LTH CA RE REFERENCE CODE: GDHC##CTIDB PUBLICATION DATE: DEC 2017 LIST OF TABLES Menstrual Disorders Global Clinical Trials Review, H##, 2017 outlines clinical trials in Menstrual Disorders.

  • Clinical Trial
  • Drug Discovery And Development
  • Hormone
  • World
  • Bayer AG

filgrastim Antisense Oligonucleotide Undisclosed MIF-## RMP-HPE KAR-## Karos Preclinical AZD-## AstraZeneca Preclinical Undisclosed Tryptophan ## Monooxygenase Inhibitor Myeloperoxidase Inhibitor Hypoxia Inducible Factor ## Alpha Activator IMMH-## Chinese Academy of Medical Sciences and

  • Drug Discovery And Development
  • World
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.
  • AMYOTROPHIC LATERAL SCLEROSIS THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS BY PROMINENT DRUGS, 2017*
  • Prominent Drugs

filgrastim ## FLX-## ## ibudilast ## Total Source: GlobalData' s Pharma Intelligence Center Clinical Trials Database (*)Trials are taken for a time period of 1995 - 2017 2017 trials are taken as of March 2017 ## Latest Clinical Trials News on Amyotrophic Lateral Sclerosis MAR ##, 2017: CO

  • Clinical Trial
  • Dementia
  • Drug Discovery And Development
  • World
  • Product Initiative
  • 10.2 NORTH AMERICA

FDA approval of Novartis' s biosimilar filing for its filgrastim biosimilar.

  • Drug Discovery And Development
  • World
  • genOway SA
  • Horizon Discovery
  • Taconic Biosciences, Inc.
  • Target
  • Clinical Trial profile. 6 Trial Title
  • Cell Therapy
  • Clinical Trial
  • Drug Discovery And Development
  • World
  • Product Initiative
  • Clinical Trial profile. 703 Trial Title
  • Clinical Trial profile. 75 Trial Title
  • Clinical Trial
  • Drug Discovery And Development
  • Leukemia
  • United States
  • World
  • Clinical Trial profile. 577 Trial Title
  • 5. All the trials included are unique trials.

Filgrastim or Lenograstim or CSF##)) Completed Phase I Interventional busulfan; filgrastim; melphalan; peripheral blood stem cells; thiotepa Fred Hutchinson Cancer Research Center National Cancer Institute US ## Mar 1998 ## Jan 2002 ## ## ## ## Official Title Clinical Trial profile. ##

  • Cancer
  • Drug Discovery And Development
  • United States
  • World
  • Novartis AG
  • NIH Research Festival Exhibit
  • Untitled

FDA approval of Novartis' s biosimilar filing for its filgrastim biosimilar.

  • Drug Discovery And Development
  • Charles River Laboratories International, Inc.
  • genOway SA
  • Horizon Discovery
  • Taconic Biosciences, Inc.
  • Clinical Trial profile. 442 Trial Title
  • Clinical Trial profile. 537 Trial Title

filgrastim; fludarabine phosphate; melphalan; natural killer cells; rituximab; T cell-depleted hematopoietic stem cells; thiotepa St.

  • Drug Discovery And Development
  • Monoclonal Antibody
  • Pharmaceutical
  • United States
  • World
  • Clinical Trial profile. 133 Trial Title
  • Clinical Trial profile. 173 Trial Title

Filgrastim-Mobilized Peripheral Blood Stem Cells for Allogeneic Transplantation with Unrelated Donors Filgrastim-Mobilized Peripheral Blood Stem Cells for Allogeneic Transplantation with Unrelated Donors GDCT## NCT##, UC-##; ##-CC-##; NCT## Immunology Hematopoiet

  • Blood Supply, Tissue Banking And Transplantation
  • Clinical Trial
  • Drug Discovery And Development
  • World
  • Product Initiative

Earlier in his career, he led development of cellular therapies at Amgen Inc. as laboratory head in the Department of Developmental Hematology, where he was also involved in the development of Filgrastim, Neulasta and Stemgen.

  • Drug Discovery And Development
  • Heart Failure
  • United States
  • Product Initiative
  • BioCardia, Inc.
  • Cutaneous B- Cell Lymphoma Pipeline Drug Profiles- Type, Class, Route
  • of Administration, Mechanism of Action, Target (2)
  • Drug Discovery And Development
  • Europe
  • North America
  • World
  • Spectrum Pharmaceuticals, Inc.
  • Clinical Trial profile. 918 Trial Title
  • Clinical Trial profile. 671 Trial Title

Filgrastim Versus Placebo Following Allogeneic Bone Marrow Transplantation Trial of Filgrastim Versus Placebo Following Allogeneic Bone Marrow Transplantation GDCT## NCT##, Immunology Graft Versus Host Disease (GVHD) Completed Phase III Interventional

  • Drug Discovery And Development
  • Pharmaceutical
  • Transplantation
  • United States
  • World
  • Clinical Trial profile. 98 Trial Title
  • Clinical Trial profile. 90 Trial Title

filgrastim; melphalan Boston Medical Center National Institutes of Health ## Nov 2000 ## Jun 2005 ## ## ## ## ## DNA Synthesis Inhibitor DNA A Multicenter Phase II Trial of Bortezomib (Velcade), Melphalan and Dexamethasone (V-MD) in Patients with Symptomatic AL-Amyloidosis or Light Chain Depo

  • Clinical Trial
  • Drug Discovery And Development
  • Therapy
  • World
  • Product Initiative

filgrastim; prednisone; rituximab; vincristine The Alliance for Clinical Trials in Oncology Montefiore Medical Center ## May 2005 ## May 2018 ## ## ## ## ## Cytotoxic To Cells Expressing B Lymphocyte Antigen CD## (B Lymphocyte Surface Antigen B## or Bp## or Leukocyte Surface Antigen Leu ##

  • Drug Discovery And Development
  • Lymphoma
  • Monoclonal Antibody
  • United States
  • World